🇺🇸 FDA
Patent

US 10676473

Solid state forms of fused heteroaromatic pyrrolidinones

granted A61KA61K9/20A61K9/48

Quick answer

US patent 10676473 (Solid state forms of fused heteroaromatic pyrrolidinones) held by Takeda Pharmaceutical Company Limited expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K9/20, A61K9/48, A61P, A61P35/00